CureMatch Events and Conferences
Precision medicine tailors treatments, practices, and products to the specific needs of a patient and their condition. Dr. Kurzrock, co-founder of CureMatch recently spoke on a Clubhouse panel addressing this topic and sharing her insights. Listen Now
CureMatch is pleased to announce our win at MedTech Insight Awards 2019 in the category of Best Technological Innovation: Digital. The judges explained their choice by describing the platform as “An exciting technology that has the potential to transform how cancer care is delivered. What an excellent use of data, and a well-deserved winning entry […]
CureMatch shares theories of 'Kolmogorov Complexity' to optimize descriptor selection at AIMed Summit. Just as a picture is worth a thousand words, a single descriptor can have the information content of a thousand descriptors embedded in it. The CureMatch presentation, titled ‘Kolmogorov Complexity, Logical Depth, etc. in Selection of Descriptors for Deep Learning in Medicine’ was given by Igor Tsigelny, Ph.D and Eden Romm, B.S.
Recognized as the “Best AI-based Solution for Healthcare” by AI Breakthrough, an independent organization that recognizes the top companies, technologies, and products in the global Artificial Intelligence (AI) market. The CureMatch precision medicine technology utilizes machine learning features and rules-based decision support to offer ranked combination cancer treatment options and has succeeded in pushing ingenuity to be identified as one of the best AI solutions in 2018.
Jessica Federer Joins Advisory Board to Advance Cancer Cures. Stephane Richard and Jessica Federer to speak at PMLS2018. SAN DIEGO, CA – June 26, 2018 – CureMatch, Inc., a digital precision oncology company bridging the gap between legacy cancer treatments and advances in personalized medicine, announces the addition of Jessica Federer to its advisory board. Ms. […]